Robo Medical Secures Tens of Millions in Funding for EndoFaster and EndoDreams Development
China-based Robo Medical Technology Co. has closed a strategic funding round amounting to “tens of...
Deals
Buchang Pharma Subsidiary Establishes Shaanxi Buchang MedData with Lingyishushu
Shandong Buchang Chuanfang, a subsidiary of China-based Buchang Pharma (SHA: 603858), announced the establishment of...
PHASE Scientific Partners with Lumos Diagnostics to Launch FebriDx in US Respiratory Market
China-based PHASE Scientific has entered into an exclusive distribution agreement with Lumos Diagnostics to introduce...
Tcelltech Secures USD 40 Million Series B Funding for TX-103 CAR-T Therapy Development
China-based Tcelltech Ltd., a developer of T-cell immunotherapies, has reportedly secured close to USD 40...
Danaher’s Cytiva Collaborates with CorrectSequence on Gene Therapy LNP Delivery System
US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced an ongoing collaboration between...
BD Merges Biosciences & Diagnostic Solutions with Waters Corporation in USD 17.5 Billion Deal
US major Becton, Dickinson and Co., (BD) is set to merge its Biosciences & Diagnostic...
Sino Biopharmaceutical Acquires Majority Stake in LaNova Medicines for USD 950.92 Million
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acquisition of a 95.09% stake in Shanghai-based...
Xgene Licenses Novel Non-Opioid Analgesic XG005 to NeuroGen for Greater China Development
Shanghai-based Xgene Pharmaceutical Inc. has entered into a licensing agreement withNeuroGen Pharma, a neurology care...
Otsuka to Acquire Cantargia’s IL-1RAP Monoclonal Antibody CAN10 for Autoimmune Diseases
Japan-based drug maker Otsuka (OTCMKTS: OTSKY) is set to acquire from Swedish biotech Cantargia AB...
Ningbo Health Gene and Biofast Biotech Partner to Advance Genetic Testing for Hereditary Diseases
Chinese firms Ningbo Health Gene Technologies Co., Ltd. and Biofast Biotechnology Co., Ltd. announced late...
Boehringer Ingelheim Licenses Spevigo to LEO Pharma for Global Dermatology Expansion
German pharmaceutical giant Boehringer Ingelheim (BI) this week announced a licensing agreement with Denmark-based dermatology...
Golden Age Health Secures Exclusive Rights to Innostellar’s Gene Therapy LX-101 in China
Singapore-based Golden Age Health, a specialty pharmaceutical company focused on rare and specialty diseases, has...
Mabwell Signs Licensing Agreement with Unilab for Denosumab Biosimilars in the Philippines
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) announced a licensing agreement with Unilab, Inc.,...
Innovent Biologics and JD Health Form Strategic Partnership to Enhance Drug Supply and Healthcare Services
China-based Innovent Biologics Inc., (HKG: 1801) and JD Health International Inc., (HKG: 6618) have officially...
Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline
China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock...
Lexenpharm Partners with AptarGroup for Single-Dose Nasal Spray Services in Greater China
China-based Lexenpharm late last week announced a strategic partnership with Aptar Pharma, a US-based global...
Eolas Therapeutics Gains Full Rights to AZD4041 for Opioid Use Disorder Development
US-based Eolas Therapeutics has entered into an agreement with its UK partner AstraZeneca (AZ, NASDAQ:...
Royal Philips and Suzhou Peixin Collaborate on AI-Powered Interventional Therapy Platform for Structural Heart Disease
Dutch device giant Royal Philips (NYSE: PHG) and China-based Suzhou Peixin Technology Co., Ltd. late...
AbbVie Licenses IGI Therapeutics’ ISB 2001 for Oncology and Autoimmune Diseases
US-based AbbVie (NYSE: ABBV) this week announced a licensing agreement with IGI Therapeutics SA, a...
JCR Pharmaceuticals Signs Licensing Agreement with AstraZeneca’s Alexion for JUST-AAV Gene Therapy Platform
Japan-based JCR Pharmaceuticals Co., Ltd. (TYO: 4552) announced a licensing agreement with UK-based AstraZeneca’s (NASDAQ:...